SIRT6 and Alzheimer disease: Furthermore, increased expression of Sirt3 and/or Sirt6 induced by treatment with nicotinamide riboside or an analog 3-iodothyronamine was associated with improved LTP in different AD mouse models (Hou et al., 2018; Bellusci et al., 2020).